Pacific Biosciences of California, Inc. (PACB)
 NASDAQ: PACB · Real-Time Price · USD
 1.940
 -0.070 (-3.48%)
  At close: Oct 30, 2025, 4:00 PM EDT
2.000
 +0.060 (3.09%)
  After-hours: Oct 30, 2025, 7:55 PM EDT
PACB Revenue
Pacific Biosciences of California had revenue of $39.77M in the quarter ending June 30, 2025, with 10.42% growth. This brings the company's revenue in the last twelve months to $156.11M, down -17.35% year-over-year. In the year 2024, Pacific Biosciences of California had annual revenue of $154.01M, down -23.19%.
Revenue (ttm) 
 $156.11M
Revenue Growth 
 -17.35%
P/S Ratio 
 3.58
Revenue / Employee 
 $271,496
Employees 
 575
Market Cap 
582.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 154.01M | -46.51M | -23.19% | 
| Dec 31, 2023 | 200.52M | 72.22M | 56.29% | 
| Dec 31, 2022 | 128.30M | -2.21M | -1.69% | 
| Dec 31, 2021 | 130.51M | 51.62M | 65.43% | 
| Dec 31, 2020 | 78.89M | -12.00M | -13.20% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 63.62B | 
| AbbVie | 58.33B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Eli Lilly and Company | 53.26B | 
| Novo Nordisk | 49.11B | 
PACB News
- 8 days ago - PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire
- 16 days ago - PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities - GlobeNewsWire
- 17 days ago - PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project - GlobeNewsWire
- 22 days ago - Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity - GlobeNewsWire
- 23 days ago - PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs - GlobeNewsWire
- 5 weeks ago - PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes - GlobeNewsWire
- 7 weeks ago - Pacific Biosciences Of California, Inc. (PACB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow - GlobeNewsWire